For the Inventor, By the Inventor

Enter assignee name

Santa Clara, CA, United States of America

Pneumrx, Inc.

USPTO Granted Patents = 47

CIPO Patents = 5

EPO Patents = 10

Trademarks = 1

Forward Citations = 927

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Mark L Mathis (35 out of 110 patents)

Patrick Peichen Wu (17 out of 49 patents)

David P Thompson (15 out of 159 patents)

4. Ronald Dieck (13 out of 27 patents)

5. David Lehrberg (13 out of 13 patents)

6. Nathan Aronson (12 out of 27 patents)

7. Glen Gong (9 out of 20 patents)

8. Jaime Vasquez (9 out of 9 patents)

9. Michael P Boutillette (5 out of 34 patents)

10. Andrew Stein (5 out of 5 patents)

11. Erin McGurk (5 out of 13 patents)

12. Timothy R Machold (3 out of 139 patents)

13. Verna Rodriguez (3 out of 3 patents)

14. Edmund J Roschak (2 out of 42 patents)

15. Kara Andersen Reiter (2 out of 2 patents)

Core Competencies:

Guidewire

Lung Volume Reduction

Chronic Obstructive Pulmonary Disease

Minimally Invasive Devices

Steerable Access Devices

Glue Composition

Pulmonary Artery Circulation

Selective Lung Tissue Dissection

Compressive Implant Structures

Enhanced Efficacy Devices

Elongated Lung Devices

Pleural Effusion Treatment

47 patents: Sort by Forward Citations

1. 10555736 - Guidewire (2020-02-11),

2. 10543053 - Containers for medical devices (2020-01-28),

3. 10537334 - Genetically-associated chronic obstructive pulmonary disease treatment (2020-01-21),

4. 10390838 - Tuned strength chronic obstructive pulmonary disease treatment (2019-08-27),

5. 10285707 - Enhanced efficacy lung volume reduction devices, methods, and systems (2019-05-14),

6. 10226257 - Lung volume reduction devices, methods, and systems (2019-03-12),

7. RE47231 - Glue composition for lung volume reduction (2019-02-11),

8. 10188398 - Cross-sectional modification during deployment of an elongate lung volume reduction device (2019-01-29),

9. 10188397 - Torque alleviating intra-airway lung volume reduction compressive implant structures (2019-01-29),

10. 10166041 - Devices, systems, methods and kits for performing selective dissection of lung tissue (2019-01-01),

11. 10058331 - Enhanced efficacy lung volume reduction devices, methods, and systems (2018-08-28),

12. 10034999 - Steerable device for accessing a target site and methods (2018-07-31),

13. D818700 - Container for medical implant (2018-05-29),

14. 9839408 - Method and system for measuring pulmonary artery circulation information (2017-12-12),

15. 9801637 - Genetically-associated chronic obstructive pulmonary disease treatment (2017-10-31),

PneumRx, Inc. is a medical technology company specializing in providing innovative solutions for the treatment of severe emphysema. They develop minimally invasive medical devices that help improve the quality of life for patients suffering from this debilitating and chronic lung disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

47 Patents

#98 in Santa Clara, CA

#1,712 in California

#7,183 in US

#14,401 in the World

Santa Clara, CA, United States of America

Pneumrx, Inc.

Forward Citations = 927

24 inventors:

Mark L Mathis (35 out of 110 patents)

Patrick Peichen Wu (17 out of 49 patents)

David P Thompson (15 out of 159 patents)

4. Ronald Dieck (13 out of 27 patents)

5. David Lehrberg (13 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…